dc.contributor.author | Ozkul O. | |
dc.contributor.author | Sever I. | |
dc.contributor.author | Ozkul B. | |
dc.date.accessioned | 2024-02-04T13:30:18Z | |
dc.date.available | 2024-02-04T13:30:18Z | |
dc.date.issued | 2024 | |
dc.identifier.issn | 15734056 | |
dc.identifier.uri | https://doi.org/10.2174/1573405620666230906092253 | |
dc.identifier.uri | http://hdl.handle.net/11446/4888 | |
dc.description.abstract | Objective: The objective of this study was to investigate the diagnostic power of apparent diffusion coefficient/coefficient of variance (ADCcV) as well as ADC parameters formed based on magnetic resonance images (MRI) in the distinction of molecular breast cancer subtypes. Methods: The study involved 205 patients who had breast cancer at stages 1-3. Estrogen receptor (EsR), progesterone receptor (PrR), human epidermal growth factor receptor 2 (Her2), and proliferation index (Ki-67) were histologically analyzed in the tumor. The correlations between the immunohistochemistry and intrinsic subtypes were analyzed using ADC and ADCcV. Results: The maximum whole tumor (WTu) ADC (p=0.004), minimum WTu ADC (p<0.001), and mean WTu ADC (p<0.001) values were significantly smaller in the EsR-positive tumors than those in the EsR-negative tumors. Compared to the PrR-negative tumors, the PrR-positive tumors showed significantly smaller maximum, minimum, and mean WTu ADC values (p=0.005, p=0.001, and p<0.001, respectively). In the comparisons of the molecular subtypes in terms of ADCcV, the p-values indicated statistically significant differences between the luminal A (lumA) group and the triple negative (TN) group, between the luminal B (lumB) group and the TN group, and between the Her2-enriched and TN groups (p<0.001, p=0.011, and p=0.004, respectively). Considering the luminal and non-luminal groups, while a significant difference was observed between the groups considering their minimum, maximum, and mean WTu ADC values, their ADCcV values were similar (p<0.001, p=0.004, and p<0.001, respectively). Conclusion: Using ADCcV in addition to ADC parameters increased the diagnostic power of diffusion weighted-MRI (DW-MRI) in the distinction of molecular subtypes of breast cancer. © 2024 The Author(s). Published by Bentham Science Publisher. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Bentham Science Publishers | en_US |
dc.relation.ispartof | Current Medical Imaging | en_US |
dc.identifier.doi | 10.2174/1573405620666230906092253 | |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | ADC | en_US |
dc.subject | ADCcV | en_US |
dc.subject | Breast cancer | en_US |
dc.subject | DW-MRI | en_US |
dc.subject | Immunohistochemistry | en_US |
dc.subject | Molecular subtype | en_US |
dc.subject | epidermal growth factor receptor 2 | en_US |
dc.subject | estrogen receptor | en_US |
dc.subject | Ki 67 antigen | en_US |
dc.subject | progesterone receptor | en_US |
dc.subject | apparent diffusion coefficient | en_US |
dc.subject | Article | en_US |
dc.subject | biopsy | en_US |
dc.subject | breast cancer | en_US |
dc.subject | breast cancer molecular subtype | en_US |
dc.subject | chemotherapy | en_US |
dc.subject | chromosome 17 | en_US |
dc.subject | diffusion weighted imaging | en_US |
dc.subject | ductal carcinoma | en_US |
dc.subject | epithelial mesenchymal transition | en_US |
dc.subject | fluorescence in situ hybridization | en_US |
dc.subject | histopathology | en_US |
dc.subject | human | en_US |
dc.subject | human tissue | en_US |
dc.subject | immunohistochemistry | en_US |
dc.subject | major clinical study | en_US |
dc.subject | nuclear magnetic resonance imaging | en_US |
dc.subject | proliferation index | en_US |
dc.subject | retrospective study | en_US |
dc.subject | T2 weighted imaging | en_US |
dc.subject | tumor volume | en_US |
dc.title | Assessment of Apparent Diffusion Coefficient Parameters and Coefficient of Variance in Discrimination of Receptor Status and Molecular Subtypes of Breast Cancer | en_US |
dc.type | article | en_US |
dc.department | DBÜ | en_US |
dc.identifier.volume | 20 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.department-temp | Ozkul, O., Department of Oncology, Istanbul Aydin University, Medicalpark Hospital, Akasya sok. No:4, Istanbul, Kucukcekmece, Turkey; Sever, I., Department of Radiology, Demiroglu Bilim University, İzzetpasa mah, Abide-i Hurriyet cad. No:166, Istanbul, Sisli, Turkey; Ozkul, B., Department of Radiology, Istanbul Atlas University, Medicine Hospital, Hamidiye mah. Anadolu cad. No:40, Istanbul, Kagithane, Turkey | en_US |
dc.identifier.pmid | 37691204 | en_US |
dc.identifier.scopus | 2-s2.0-85178145709 | en_US |
dc.authorscopusid | 57201667514 | |
dc.authorscopusid | 57299310900 | |
dc.authorscopusid | 56604118900 | |